NGM Clinical Study Site

Durham, North Carolina 27710

0 studies enrolling now · 2 studies all time

What they study most

Compensated Cirrhosis, NASH - Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis

Studies at this site

• Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3) — Completed
• Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) — Completed